Related Experiment Video
Updated: Sep 11, 2025
09:51
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
1.0K
Exploring the Therapeutic Potential of Natural Compounds Targeting Macro-Autophagy in OP Management: A Comprehensive
Nima Montazeri-Najafabady1, Pooneh Mokaram2, Sanaz Dastghaib1,3
1Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Journal of Cellular Biochemistry
|August 11, 2025
Summary
Natural products that regulate autophagy show promise for treating osteoporosis (OP) by improving bone cell function. Further research is needed to explore their mechanisms and clinical effects for safer OP treatments.
Area of Science:
- Biomedical Science
- Cell Biology
- Gerontology
Background:
- Osteoporosis (OP) is a significant health issue in the elderly, characterized by bone loss and structural deterioration.
- Current OP medications have limitations, including prolonged use issues and side effects, driving interest in natural, non-pharmacological interventions.
- Autophagy disruption in bone cells (osteoblasts and osteoclasts) is implicated in OP development.
Purpose of the Study:
- To review natural products that modulate autophagy and their effects on bone cells.
- To explore the potential of these natural compounds as therapeutic agents for osteoporosis.
- To highlight the role of autophagy as a target for novel OP treatments.
Main Methods:
- Comprehensive literature review of natural products impacting autophagy and bone metabolism.
- Analysis of studies investigating the effects of natural compounds on osteoblastic and osteoclastic activity.
- Examination of the relationship between autophagy pathways and osteoporosis pathogenesis.
Main Results:
- Natural products regulating autophagy can enhance osteoblastic differentiation and bone formation.
- These compounds may inhibit osteoclastic resorption, a key process in OP.
- Autophagy modulation by natural products presents a potential strategy for OP prevention and treatment.
Conclusions:
- Natural products targeting autophagy offer a promising avenue for developing safer and more effective osteoporosis therapies.
- Understanding the intricate link between autophagy and OP can lead to personalized medical interventions.
- Further research is essential to elucidate mechanisms, clinical efficacy, and safety profiles of these natural compounds for OP treatment.
Related Concept Videos
01:25Analgesia and Pain Management
791
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
791
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
01:44Nociception
29.4K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
29.4K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
433
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
433
01:22Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
01:18Autophagic Cell Death
3.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K